Venture Capital Brex Lands $300 Million Series D-2 SAN FRANCISCO — Brex, a company providing financial services for startups, has raised an additional… EditorJanuary 14, 2022
Venture Capital Roche Invests $290 Million in Freenome SOUTH SAN FRANCISCO — Freenome, a privately held biotech company, announced that Swiss healthcare giant… EditorJanuary 13, 2022January 13, 2022
Venture Capital Qnovo Closes $24 Million Financing NEWARK — Qnovo, a developer of battery management software, has closed $24 million in Series-C financing.… EditorJanuary 13, 2022
Venture Capital Envoy Scores $111 Million Series C SAN FRANCISCO — Envoy, a workplace platform that helps companies reopen safe and flexible workplaces,… EditorJanuary 13, 2022
Venture Capital Pediatric Mental Health Company Little Otter Lands $22 Million SAN FRANCISCO – Little Otter, a digital mental health company to provide tools and treatment… EditorJanuary 12, 2022
Venture Capital WEKA Scores $73 Million Led by Hitachi Ventures CAMPBELL — WEKA, the data platform for AI, announced that Hitachi Ventures led its recent… EditorJanuary 8, 2022
Venture Capital Softbank Vision Fund Leads $110 Million Round in Labelbox SAN FRANCISCO — Labelbox, a training data platform for enterprise machine learning applications, has closed… EditorJanuary 8, 2022January 8, 2022
Venture Capital Prevedere Completes $25 Million Financing SUNNYVALE – Prevedere, a company developing Intelligent Forecasting software using AI, has completed $25 million… EditorJanuary 6, 2022January 6, 2022
Venture Capital Syntegra Closes $5.625 Million in Seed Funding SAN FRANCISCO — Syntegra, a leader in synthetic healthcare data generation, has closed its seed financing, bringing… EditorJanuary 5, 2022
Venture Capital Avoma Reels In $12 Million Series A PALO ALTO — Avoma, a provider of a Meeting Lifecycle Assistant, has raised $12 million… EditorJanuary 5, 2022January 5, 2022
Venture Capital Mperativ Launches From Stealth With $6 Million SAN FRANCISCO – Mperativ has launched from stealth and announced $6 million in funding, which includes… EditorDecember 31, 2021
Venture Capital Ambys Medicines Completes $47 Million Series A Extension SOUTH SAN FRANCISCO — Ambys Medicines, a company pioneering cell-based therapies for severe liver diseases,… EditorDecember 30, 2021